Trinity biotech announces breakthrough results from pre-pivotal trial of disruptive continuous glucose monitoring (cgm) technology

Trinity biotech's patented technology represents a paradigm shift in the global cgm market, projected to exceed $20 billion by 2029 trinity biotech's patented technology represents a paradigm shift in the global cgm market, projected to exceed $20 billion by 2029
TRIB Ratings Summary
TRIB Quant Ranking